Ratings Target Healthcare REIT PLC

Equities

THRL

GB00BJGTLF51

Market Closed - London S.E. Other stock markets 16:35:28 08/05/2024 BST			5-day change	1st Jan Change
79.6 ^GBX	-0.50%		+1.40%	-7.76%

04-12	JPMorgan raises Taylor Wimpey, Persimmon	AN
03-12	Target Healthcare interim net asset value and contractual rent grow	AN

Summary

The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the best yield companies with high dividend expectations.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
For the past twelve months, EPS forecast has been revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
One of the major weak points of the company is its financial situation.
The company's "enterprise value to sales" ratio is among the highest in the world.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Residential REITs

	1st Jan change	Capi.	ESG Refinitiv
TARGET HEALTHCARE REIT PLC	-7.76%	622M	D+
EQUITY RESIDENTIAL	+8.08%	25.28B	B
INVITATION HOMES INC.	+1.73%	21.43B	B-
ESSEX PROPERTY TRUST, INC.	+2.65%	16.54B	B+
MID-AMERICA APARTMENT COMMUNITY, INC.	-1.09%	15.91B	B
SUN COMMUNITIES, INC.	-12.67%	14.52B	C
AMERICAN HOMES 4 RENT	+0.56%	13.36B	B
UDR INC.	-0.05%	12.83B	B
EQUITY LIFESTYLE PROPERTIES, INC.	-11.07%	11.75B	B-
CAMDEN PROPERTY TRUST	+4.91%	11.29B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes